Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques
Using OFR Software to Observe the Effects of Inclisiran Combined With Statins on the Morphology and Vascular Function of Coronary Vulnerable Plaques
Nanjing First Hospital, Nanjing Medical University
40 participants
Mar 15, 2024
INTERVENTIONAL
Conditions
Summary
Effects of inclisiran + statins vs. statins on the morphology and vascular function of coronary vulnerable plaques, in order to provide a better treatment and more detailed imaging basis for the treatment of coronary vulnerable plaques.
Eligibility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The patients in Inclisiran group were given drugs three times in total. The first needle was injected subcutaneously with 284mg(1.5ml solution) after entering the group, the second needle was injected three months later and the third needle was injected at the ninth month.
Rosuvastatin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06338293